Diabetic Macular Edema Market to Rear Excessive Growth during 2016 – 2025 ; Bayer AG, F. Hoffmann-La Roche Ltd., Alimera Sciences, Inc., Regeneron Pharmaceuticals, Inc., Pfizer Inc.,Allergan plc, Novartis AG

Industry Trend Analysis:
The Global Diabetic Macular Edema (DME) Market is expected to be around $4 billion by 2025. Some of the key factors driving this market are high prevalence of diabetic retinopathy and diabetic macular edema and increasing prevalence of geriatric population around the world. According to the National Center for biotechnology Information, DME is expected to affect around 592 million people by 2035. With such high incidence of DME, the demand for therapies to treat DME is expected to considerably increase during the forecast period. Older adults are more susceptible to diabetes. With increasing prevalence of older population globally, the risk of DME is also expected to increase during the forecast period.

For more information, click on the below link @ https://www.crystalmarketresearch.com/report/diabetic-macular-edema-market .

Major Participants:
Some of the key players operating in this market are, Bayer AG, F. Hoffmann-La Roche Ltd., Alimera Sciences, Inc., Regeneron Pharmaceuticals, Inc., Pfizer Inc.,Allergan plc, Novartis AG and Bausch & Lomb Incorporated (acquired by Valeant Pharmaceuticals International, Inc.).

Diabetic Macular Edema Market Segmentation:
By Indication Type:
Diffuse Diabetic Macular Edema
Focal Diabetic Macular Edema

By Treatment Type:
Corticosteroid Therapy
Grid Laser Photocoagulation
Implants
Anti-vascular Endothelial Growth Factor Therapy
Focal Laser Treatment

By End User:
Ophthalmic Clinics
Hospitals
Ambulatory Surgical Centers

Click to Request a Sample @ https://www.crystalmarketresearch.com/report-sample/HC0682 .

Regional Insights:
North America held a substantial share of the global DME market in 2016 owing to high prevalence of diabetes, high awareness among people about DME and the available treatment options and better reimbursement policies in the region. The region is expected to maintain its dominance over the market during the forecast period. European DME market is expected to show lucrative growth during the forecast period owing to presence of large patient pool in the region.

Table of Contents:
1.Introduction
2.Executive Summary
3.Market Overview
4.Diabetic Macular Edema Market, By Indication Type
5.Diabetic Macular Edema Market, By Treatment Type
5.1.Introduction
5.2.Diabetic Macular Edema Market Assessment and Forecast, By Treatment Type, 2016-2025
5.3.Corticosteroid Therapy
5.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.4.Grid Laser Photocoagulation
5.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.5.Implants
5.5.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.6.Anti-vascular Endothelial Growth Factor Therapy
5.6.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
5.7.Focal Laser Treatment
5.7.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)
6.Diabetic Macular Edema Market, By End User
7.Diabetic Macular Edema Market, By Region
8.Company Profiles
...

Ask Questions to Expertise at @ https://www.crystalmarketresearch.com/send-an-enquiry/HC0682 .

Treatment Type Outlook :
Corticosteroid therapy can be used to treat patients suffering from recurrent or advanced DME. Corticosteroids are anti-inflammatory non-specific agents and can be effective when administered intravitreally. Grid laser photocoagulation is a standard therapy used for treatment of DME. The laser is applied in a grid-like pattern in order to clear scars that lead to vision loss and blind spots and to destroy the damaged tissue. Implants filled with drugs are also widely used for treating patients with DME caused due to retinal vein occlusion which is one of the common causes leading to macular edema.

List of Tables:
Table 1.Global Diabetic Macular Edema Market, By Indication Type ($Million), 2016-2025
Table 2.Diffuse Diabetic Macular Edema Market, By Region ($Million), 2016-2025
Table 3.Focal Diabetic Macular Edema Market, By Region ($Million), 2016-2025
Table 4.Global Diabetic Macular Edema Market, By Treatment Type ($Million), 2016-2025
Table 5.Corticosteroid Therapy Market, By Region ($Million), 2016-2025
...

To avail discount, please click on the link @ https://www.crystalmarketresearch.com/check-discount/HC0682 .

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com

This release was published on openPR.